ANI Pharmaceuticals, Inc. (BST:BSFA)

Market Cap	1.45B +11.1%
Revenue (ttm)	801.13M +37.0%
Net Income	72.80M
EPS	3.38
Shares Out	n/a
PE Ratio	19.86
Forward PE	8.39
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	16
Open	67.00
Previous Close	68.00
Day's Range	67.00 - 69.50
52-Week Range	49.60 - 84.00
Beta	n/a
RSI	50.66
Earnings Date	May 8, 2026

About ANI Pharmaceuticals

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, gr...

• Industry: Pharmaceutical Preparations
• Founded: 2001
• Employees: 970
• Stock Exchange: Stuttgart Stock Exchange
• Ticker Symbol: BSFA

Financial Performance

Financial numbers in USD